RT Journal Article
SR Electronic
T1 The effects of time-restricted eating vs. standard dietary advice on weight, metabolic health and the consumption of processed food: A pragmatic randomised controlled trial in community-based adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.29.21250725
DO 10.1101/2021.01.29.21250725
A1 Phillips, Nicholas Edward
A1 Mareschal, Julie
A1 Schwab, Nathalie
A1 Manoogian, Emily N.C.
A1 Borloz, Sylvie
A1 Ostinelli, Giada
A1 Gauthier-Jaques, Aude
A1 Umwali, Sylvie
A1 Rodriguez, Elena Gonzalez
A1 Aeberli, Daniel
A1 Hans, Didier
A1 Panda, Satchidananda
A1 Rodondi, Nicolas
A1 Naef, Felix
A1 Collet, Tinh-Hai
YR 2021
UL http://medrxiv.org/content/early/2021/03/04/2021.01.29.21250725.abstract
AB Weight loss is key to control the increasing prevalence of metabolic syndrome (MS) and its components, i.e. central obesity, hypertension, prediabetes, and dyslipidaemia. We characterised the relationships between eating duration, unprocessed and processed food consumption, and metabolic health. During 4 weeks of observation, 213 adults used a smartphone application to record food and drink consumption, which was annotated for food processing levels following the NOVA classification. Consumption of unprocessed food items showed the highest number of significant associations with MS components after age and sex. In a pragmatic randomised controlled trial, we compared the metabolic benefits of 12h time-restricted eating (TRE) to standard dietary advice (SDA) in 54 adults with an eating duration >14h and at least one MS component. After 6 months, those randomised to TRE lost 1.6% of initial body weight (SD 2.9, p=0.01), compared to the absence of weight loss with SDA (−1.1%, SD 3.5, p=0.19). There was no significant difference in weight loss between TRE and SDA (between-group difference −0.88%, 95% confidence interval −3.1 to 1.3, p=0.43). Our results show the potential of smartphone records to predict metabolic health and highlight that further research is needed to understand individual responses to TRE.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03241121Funding StatementThis research was funded by the Swiss National Science Foundation (grant no PZ00P3-167826 to T.H.C.), the Swiss Society of Endocrinology and Diabetes (2017 Young Investigator prize to T.H.C.), and the Strategic Focal Area Personalized Health and Related Technologies (PHRT) of the ETH Domain (grant no 2018-427 to N.E.P.). T.H.C.'s research is also supported by grants from the Leenaards Foundation, the Vontobel Foundation, and the Swiss Multiple Sclerosis Society. D.A.'s research is supported by the Novartis Foundation for biomedical research and the Alfred und Anneliese Sutter-Stöttner Stiftung. G.O. is the recipient of a doctorate scholarship by the Fonds de recherche Québec Santé (FRQS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the guidelines of the Declaration of Helsinki and the ICH E6 Good Clinical Practice. It was approved by the Ethics Committees of Vaud canton and Bern canton, Switzerland (protocol no 2017-00487).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data presented in this study are available upon reasonable request to the corresponding author. The data are not publicly available due to confidentiality reasons.